HER2
Clinical trials for HER2 explained in plain language.
Never miss a new study
Get alerted when new HER2 trials appear
Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple therapy shows promise against hard-to-treat bile duct cancer
Disease control OngoingThis study tests a combination of chemotherapy (gemcitabine/cisplatin) plus two targeted drugs (trastuzumab and pembrolizumab) as a first treatment for people with HER2-positive bile duct or gallbladder cancer that cannot be removed by surgery. About 24 adults will receive the tr…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
AI could replace biopsies for HER2 testing in bladder cancer
Diagnosis ENROLLING_BY_INVITATIONThis study enrolls 4,000 people with urothelial carcinoma (bladder cancer) to test whether artificial intelligence can accurately predict HER2 protein levels using MRI scans and tissue images. The goal is to guide targeted therapy decisions without needing invasive biopsies. Rese…
Matched conditions: HER2
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Diagnosis
Last updated May 26, 2026 04:35 UTC